Helicobacter pylori antimicrobial resistance and gene variants in Shandong Province
Abstract
The emergence of antibiotic resistance in Helicobacter pylori led to a sharp decline in eradication rates, but there are limited data regarding the prevalence and genetic mechanisms of antibiotic resistance in Shandong. This study aims to assess the prevalence and molecular mechanisms of H. pylori antibiotic resistance to commonly used antibiotics in Shandong populations. Antimicrobial susceptibility testing was performed for clarithromycin, levofloxacin, metronidazole, tetracycline, rifampicin, amoxicillin, azithromycin, and moxifloxacin using E-test method. PCR amplified resistance-associated genes for all the strains, and 32 were whole-genome sequenced. 62 H. pylori strains were obtained and the infection rate was 30.1% (62/206). No resistance to amoxicillin was observed. Two and four strains were resistant to tetracycline and rifampicin, respectively, and no resistance-associated mutations were found in the 16S rRNA and rpoB genes. The resistance rates of azithromycin, clarithromycin, levofloxacin, and moxifloxacin were 56.45% (35/62), 33.87% (21/62), 48.39% (30/62), and 56.45% (35/62), respectively. The percentages of dual, triple, and quadruple resistance were 32.26% (20/62), 24.19% (15/62), and 1.61% (1/62), respectively, and only one isolate was resistant to quadruple antibiotics. Phenotypic resistance associated with the A2143G mutations in 23S rRNA for azithromycin and clarithromycin (kappa coefficient, 0.808 and 0.671, respectively), and gyrA mutations…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.